XNASDCGO
Market cap426mUSD
Jan 15, Last price
4.18USD
1D
2.20%
1Q
23.30%
IPO
-59.42%
Name
DocGo Inc
Chart & Performance
P/E
62.20
P/S
0.68
EPS
0.07
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
624m
+41.72%
Net income
7m
-80.17%
CFO
-64m
L
Earnings
Feb 26, 2025
Profile
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 624,289 41.72% | 440,516 38.21% | |||
Cost of revenue | 592,802 | 408,119 | |||
Unusual Expense (Income) | |||||
NOPBT | 31,487 | 32,397 | |||
NOPBT Margin | 5.04% | 7.35% | |||
Operating Taxes | 6,245 | (7,961) | |||
Tax Rate | 19.83% | ||||
NOPAT | 25,242 | 40,359 | |||
Net income | 6,858 -80.17% | 34,584 45.66% | |||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | (728) | (1,751) | |||
BB yield | 0.12% | 0.24% | |||
| Debt | |||||
Debt current | 31,335 | 5,723 | |||
Long-term debt | 36,589 | 32,205 | |||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | 8,085 | (120,006) | |||
| Cash flow | |||||
Cash from operating activities | (64,222) | 28,870 | |||
CAPEX | (7,585) | (5,498) | |||
Cash from investing activities | (29,882) | (38,448) | |||
Cash from financing activities | 1,119 | (6,180) | |||
FCF | (95,296) | 35,892 | |||
| Balance | |||||
Cash | 59,286 | 157,335 | |||
Long term investments | 554 | 598 | |||
Excess cash | 28,625 | 135,908 | |||
Stockholders' equity | (15,523) | (22,524) | |||
Invested Capital | 367,191 | 321,366 | |||
ROIC | 7.33% | 12.72% | |||
ROCE | 8.95% | 10.84% | |||
| EV | |||||
Common stock shares outstanding | 105,618 | 102,976 | |||
Price | 5.59 -20.93% | 7.07 -24.39% | |||
Market cap | 590,404 -18.90% | 728,039 -17.92% | |||
EV | 602,865 | 613,730 | |||
EBITDA | 47,919 | 42,963 | |||
EV/EBITDA | 12.58 | 14.29 | |||
Interest | 763 | ||||
Interest/NOPBT | 2.35% | ||||